TWIN FOCUS CAPITAL PARTNERS, LLC
Position in CGEM — Cullinan Therapeutics, Inc.
CIK 1387761
Boston, MA
Position in CGEM
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$10,843,854
+$2,381,956 QoQ
Shares Held
595,489
0.0% QoQ
Ownership
0.925%
of shares outstanding
% of Portfolio
3.82%
of 13F equity value
Holder Rank
#22
of 184 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWIN FOCUS CAPITAL PARTNERS, LLC holds $24,101,992 across 3 Biotechnology names. CGEM ranks #2 (45.0% of the industry book) .
All Filings in CGEM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,843,854 | 595,489 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $8,461,898 | 595,489 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,163,311 | 595,489 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,531,249 | 595,489 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,484,032 | 595,489 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,507,851 | 595,489 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,253,056 | 595,489 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,968,485 | 595,489 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,385,328 | 595,489 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||